Clinical Discussions in Antithrombotic Therapy Management : A Delphi Consensus Panel
{{output}}
For some years now, direct-acting oral anticoagulants (DOACs) have entered the clinical practice for stroke prevention in non-valvular atrial fibrillation (NVAF) or prevention and treatment of venous thromboembolism (VTE). However, there is uncertainty on DOAC... ...
